Conferences Muna Therapeutics is attending in 2026
Muna Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026: CTAD 2026 (on the program) and Biomarkers Europe 2026 (on the program). Muna Therapeutics is a biotechnology company developing treatments for neurodegenerative diseases, including Alzheimer’s disease. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
19th Clinical Trials on Alzheimer’s Disease (CTAD) ConferenceAlzheimer’s trial sponsors & biomarker vendorsOfficial site |
Boston, MA ~1.7k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 poster Attendee mix: Evenly mixed industry & academia; Alzheimer’s trial sponsors, academic trialists, CRO, eCOA and biomarker teams
Attending
|
Open the guide Search and filter attendees |
Biomarkers, CDx & Precision Medicine 2026 (with NextGen Omics, Tech & Data Europe)European biomarker & multi-omics leadsOfficial site |
Past Basel, Switzerland ~1k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 panel discussion Attendee mix: Evenly mixed biopharma & vendors; biomarker, multi-omics and pathology leads from pharma, biotech, academia and healthcare
Attending
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Muna Therapeutics’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Muna Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!